Cerus (CERS) Operating Margin Growth (1y) (2011 - 2026)
Cerus (CERS) Operating Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.82 Bn | 176.53 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 68.59 Bn | 67.14 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 851.00 |
| 7 | GE HealthCare Technologies | 28.11 Bn | 25.82 Bn | 1.98 Bn | -313.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.28 Bn | 21.15 Bn | 2.07 Bn | 241.00 |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 1,288.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,288.00 |
| Dec 31, 2025 | 153.00 |
| Sep 30, 2025 | 15,447.00 |
| Jun 30, 2025 | -61,303.00 |
| Mar 31, 2025 | 726.00 |
| Dec 31, 2024 | -254.00 |
| Sep 30, 2024 | 285,793.00 |
| Jun 30, 2024 | 1,721.00 |
| Mar 31, 2024 | 8,004.00 |
| Dec 31, 2023 | 585.00 |
| Sep 30, 2023 | -288,603.00 |
| Jun 30, 2023 | -1,329.00 |
| Mar 31, 2023 | -3,431.00 |
| Dec 31, 2022 | 77.00 |
| Sep 30, 2022 | 7,640.00 |
| Jun 30, 2022 | 8,165.00 |
| Mar 31, 2022 | 10,366.00 |
| Dec 31, 2021 | 928.00 |
| Sep 30, 2021 | 208,713.00 |
| Jun 30, 2021 | 269.00 |